These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 16633860

  • 1. Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches.
    Langley RG, Ho V, Lynde C, Papp KA, Poulin Y, Shear N, Toole J, Zip C.
    J Cutan Med Surg; 2006; 9 Suppl 1():18-25. PubMed ID: 16633860
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biologic therapeutics in the treatment of psoriasis. Part 1: review.
    Langley RG, Gupta AK, Cherman AM, Inniss KA.
    J Cutan Med Surg; 2007; 11(3):99-122. PubMed ID: 17511926
    [Abstract] [Full Text] [Related]

  • 4. An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis.
    Weinberg JM.
    Clin Ther; 2003 Oct; 25(10):2487-505. PubMed ID: 14667953
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials.
    Brimhall AK, King LN, Licciardone JC, Jacobe H, Menter A.
    Br J Dermatol; 2008 Aug; 159(2):274-85. PubMed ID: 18547300
    [Abstract] [Full Text] [Related]

  • 6. Systemic therapies for psoriasis: understanding current and newly emerging therapies.
    Sobell JM, Hallas SJ.
    Semin Cutan Med Surg; 2003 Sep; 22(3):187-95. PubMed ID: 14649586
    [Abstract] [Full Text] [Related]

  • 7. Use of biologic therapeutics in difficult-to-treat psoriasis.
    Lynde C.
    J Cutan Med Surg; 2009 Sep; 13(1):6-17. PubMed ID: 19298766
    [Abstract] [Full Text] [Related]

  • 8. Biological agents in the treatment of psoriasis.
    Tzu J, Krulig E, Cardenas V, Kerdel FA.
    G Ital Dermatol Venereol; 2008 Oct; 143(5):315-27. PubMed ID: 18833073
    [Abstract] [Full Text] [Related]

  • 9. [New systemic treatments for psoriasis: etanercept, infliximab, adalimumab, efalizumab and alefacept].
    Bos WE, Thio HB, Neumann HA, van der Fits L, Prens EP.
    Ned Tijdschr Geneeskd; 2006 May 13; 150(19):1065-70. PubMed ID: 16733982
    [Abstract] [Full Text] [Related]

  • 10. Biologic therapies for psoriasis. A systematic review.
    Boehncke WH, Prinz J, Gottlieb AB.
    J Rheumatol; 2006 Jul 13; 33(7):1447-51. PubMed ID: 16724367
    [Abstract] [Full Text] [Related]

  • 11. Efalizumab: integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis.
    Lynde C.
    J Cutan Med Surg; 2006 Jul 13; 9 Suppl 1():1-3. PubMed ID: 16633863
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients.
    Young MS, Horn EJ, Cather JC.
    Expert Rev Clin Immunol; 2011 Jan 13; 7(1):9-13. PubMed ID: 21162644
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Advances in therapy for psoriasis: an overview of infliximab, etanercept, efalizumab, alefacept, adalimumab, tazarotene, and pimecrolimus.
    Saini R, Tutrone WD, Weinberg JM.
    Curr Pharm Des; 2005 Jan 13; 11(2):273-80. PubMed ID: 15638763
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept.
    Weinberg JM, Saini R.
    Cutis; 2003 Jan 13; 71(1):25-9. PubMed ID: 12553627
    [Abstract] [Full Text] [Related]

  • 19. Use of biological agents in patients with moderate to severe psoriasis: a cohort-based perspective.
    Jones-Caballero M, Unaeze J, Peñas PF, Stern RS.
    Arch Dermatol; 2007 Jul 13; 143(7):846-50. PubMed ID: 17638727
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.